Bolt Biotherapeutics, Inc. BOLT Q2 2025 earnings
Reported August 14, 2025 · Before market open
Revenue$1.8MBeat by $958.2K
EPS-$4.46Beat by $1.94
Revenue estimate$845.8K
EPS estimate-$6.40
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$500.0K
EPS estimate-$3.39
Versus estimates
Revenue
Diluted EPS
Ask the moment Bolt Biotherapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Bolt Biotherapeutics, Inc. report Q2 2025 earnings?
- Bolt Biotherapeutics, Inc. (BOLT) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Bolt Biotherapeutics, Inc.'s Q2 2025 revenue and EPS?
- Bolt Biotherapeutics, Inc. reported revenue of $1.8M and eps of $-4.46 for Q2 2025.
- Did Bolt Biotherapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $845.8K by $958.2K. EPS beat the consensus estimate of $-6.40 by $1.94.
- How did Bolt Biotherapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 41.5% from $1.3M a year earlier and eps declined 696.4% from $-0.56.
- Where can I find Bolt Biotherapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001641281-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.